![Daniel Tesfa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Tesfa worked as a Medical Director at Swedish Orphan Biovitrum AB, Chief Medical Officer at Vivesto AB, and Country Medical Manager at Roche AB. He also worked as the Head of Oncology & Hematology at Bayer AB from 2018 to 2020.
Dr. Tesfa holds a doctorate degree from Karolinska Institutet and the University of Lund.
| Unternehmen | Position | Ende |
|---|---|---|
Bayer AB
 Bayer AB Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Corporate Officer/Principal | 01.01.2020 |
Roche AB
 Roche AB Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical goods | Corporate Officer/Principal | - |
| SWEDISH ORPHAN BIOVITRUM AB | Technik-/Wissenschafts-/F&E-Leiter | - |
| VIVESTO AB | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 6 |
|---|---|
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivesto AB
 Vivesto AB Pharmaceuticals: GenericHealth Technology Develops cancer drugs based on nanotechnology for human and veterinary use | Health Technology |
Roche AB
Roche AB Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical goods | Health Technology |
Bayer AB
Bayer AB Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
